Can Cyprus Afford Luspatercept? A Budget Impact Analysis of the Reimbursement of Luspatercept for the Management of Thalassaemia in Cyprus

Objective This study aims to estimate the budget impact of luspatercept reimbursement as an adjuvant to the standard management of β-thalassaemia major in Cyprus, from a societal perspective, and assess the financial feasibility of its inclusion in the β-thalassaemia armamentarium. Methods A 5-year...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PharmacoEconomics - Open 2024-05, Vol.8 (3), p.471-480
Hauptverfasser:	Pitsillidou, Olga, Petrou, Panagiotis, Postma, M. J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis Blood & organ donations Blood diseases Blood transfusions Budget Chelation therapy Disease management Impact analysis Iron Market shares Medical prognosis Medical research Medicine Medicine & Public Health Medicine, Experimental Original Original Research Article Patients Pharmacoeconomics and Health Outcomes Public health Reimbursement
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!